Ratelle S, Yokoe D, Whelan M, Tang Y, Platt R, Blair R, Tao G, Irwin K
Massachusetts Department of Public Health, Boston, USA.
Sex Transm Dis. 2001 Apr;28(4):232-5. doi: 10.1097/00007435-200104000-00008.
Cost containment has led to a concern that health maintenance organization-insured patients presenting with complaints of urethritis may be treated without being tested.
To determine the proportion of men presenting with symptoms of urethritis who are tested for Chlamydia trachomatis and Neisseria gonorrhoeae.
Reviews were performed on 196 randomly selected patient records with an outpatient visit and a diagnostic code consistent with urethritis between 1995 and 1997. Data were collected on demographics, diagnostic testing, and treatment.
Diagnostic testing for C trachomatis and N gonorrhoeae was performed, respectively, in 92.3% and 83.2% of the men presenting at an initial visit with complaints of urethritis. Altogether, 98.2% of the patients who met the Centers for Disease Control criteria for documenting urethritis were tested for C trachomatis and N gonorrhoeae.
Diagnostic testing for C trachomatis and N gonorrhoeae is nearly universal in this multispecialty group practice setting, facilitating surveillance and public health efforts.
成本控制引发了人们对以下情况的担忧，即患有尿道炎症状的健康维护组织参保患者可能未经检测就接受治疗。
确定出现尿道炎症状的男性中接受沙眼衣原体和淋病奈瑟菌检测的比例。
对1995年至1997年间随机抽取的196份患者记录进行回顾，这些记录来自门诊就诊且诊断代码与尿道炎相符的患者。收集了人口统计学、诊断检测和治疗方面的数据。
在初次就诊时主诉尿道炎的男性中，分别有92.3%和83.2%的人接受了沙眼衣原体和淋病奈瑟菌的诊断检测。总体而言，符合疾病控制中心记录尿道炎标准的患者中有98.2%接受了沙眼衣原体和淋病奈瑟菌检测。
在这种多专科团体执业环境中，沙眼衣原体和淋病奈瑟菌的诊断检测几乎是普遍进行的，这有助于监测和公共卫生工作。
